Berkeley, CA, United States of America

Joan Garbarino



Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Joan Garbarino: Innovator in Ubiquitin-Lytic Peptide Research

Introduction

Joan Garbarino is a distinguished inventor based in Berkeley, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of ubiquitin-lytic peptide fusion polypeptides. With a total of 3 patents, her work has advanced the understanding and application of gene promoters and fusion proteins.

Latest Patents

Garbarino's latest patents include innovative methods for creating stabilized ubiquitin-lytic peptide fusion polypeptides. One of her notable patents describes a method of sub-cloning nucleic acid sequences coding for lytic peptides into a plasmid vector. This vector comprises a promoter and ubiquitin polypeptide coding sequence, wherein the ubiquitin polypeptide sequence is linked to the 5' end of the lytic peptide nucleic acid sequence and is translated as a fusion polypeptide. This groundbreaking work has implications for various applications in biotechnology and medicine.

Career Highlights

Throughout her career, Joan Garbarino has worked with reputable organizations, including Demegen, Inc. and the United States of America, as represented by the Secretary of Agriculture. Her expertise in the field has led to significant advancements in the understanding of peptide fusion and its applications.

Collaborations

Garbarino has collaborated with notable professionals in her field, including William R. Belknap and Jesse M. Jaynes. These collaborations have further enriched her research and contributed to the success of her innovative projects.

Conclusion

Joan Garbarino's contributions to the field of biotechnology through her patents and collaborations highlight her role as a leading inventor. Her work continues to influence advancements in the understanding of ubiquitin-lytic peptide fusion polypeptides.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…